{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:40:54Z","timestamp":1763001654387,"version":"3.45.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002152","name":"International Trachoma Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"\u201cla Caixa\u201d Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.lanwpc.2021.100293","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T02:07:06Z","timestamp":1635905226000},"page":"100293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial"],"prefix":"10.1016","volume":"18","author":[{"given":"Lucy N","family":"John","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Gonzalez-Beiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marti","family":"Vall-Mayans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reman","family":"Kolmau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Houinei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Wangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-4743","authenticated-orcid":false,"given":"Michael","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3266-8868","authenticated-orcid":false,"given":"Oriol","family":"Mitja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2021.100293_bib0001","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1706854","article-title":"A Trial of a Triple-Drug Treatment for Lymphatic Filariasis","volume":"379","author":"King","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJMoa1408586","article-title":"Mass Treatment with Single-Dose Azithromycin for Yaws","volume":"372","author":"Mitj\u00e0","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0003","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2471\/BLT.05.28696","article-title":"TheSAFE strategy for trachoma control: using operational research for policy, and implementation","volume":"84","author":"Emerson","year":"2006","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0004","unstructured":"World Health Organization. WHO | Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021\u20132030. World Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240010352 (accessed Aug 3, 2020)."},{"key":"10.1016\/j.lanwpc.2021.100293_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1179\/2047773211Y.0000000010","article-title":"Cost-effectiveness of triple drug administration (TDA) with praziquantel, ivermectin and albendazole for the prevention of neglected tropical diseases in Nigeria","volume":"105","author":"Evans","year":"2011","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0006","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2915.1999.00159.x","article-title":"Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival","volume":"13","author":"Bockarie","year":"1999","journal-title":"Med Vet Entomol"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0007","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0001-706X(99)00087-X","article-title":"Treatment with ivermectin reduces the high prevalence of scabies in a village in Papua New Guinea","volume":"75","author":"Bockarie","year":"2000","journal-title":"Acta Trop"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0008","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1016\/S2214-109X(15)00011-X","article-title":"Global epidemiology of yaws: a systematic review","volume":"3","author":"Mitj\u00e0","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0009","unstructured":"Guideline: Alternative Mass Drug Administration Regimens to Eliminate Lymphatic Filariasis. Geneva: World Health Organization; 2017. PMID: 29565523"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0010","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass Drug Administration for Scabies Control in a Population with Endemic Disease","volume":"373","author":"Romani","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lanwpc.2021.100293_bib0011","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4269\/ajtmh.18-0018","article-title":"Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania","volume":"99","author":"Martin","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0012","doi-asserted-by":"crossref","unstructured":"John LN, Bjerum C, Martinez PM, et\u00a0al. Pharmacokinetic and safety study of co-administration of albendazole, diethylcarbamazine, Ivermectin and azithromycin for the integrated treatment of Neglected Tropical Diseases. Clin Infect Dis. 2020 Aug 20:ciaa1202. Epub ahead of print. PMID: 32818264","DOI":"10.1093\/cid\/ciaa1202"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0013","doi-asserted-by":"crossref","first-page":"e1132","DOI":"10.1016\/S2214-109X(18)30397-8","article-title":"Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial","volume":"6","author":"Romani","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lanwpc.2021.100293_bib0014","doi-asserted-by":"crossref","first-page":"e2221","DOI":"10.1371\/journal.pntd.0002221","article-title":"A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali","volume":"7","author":"Coulibaly","year":"2013","journal-title":"PLoS Negl Trop Dis"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606521002029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606521002029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:37:26Z","timestamp":1763001446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606521002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":14,"alternative-id":["S2666606521002029"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100293","relation":{},"ISSN":["2666-6065"],"issn-type":[{"type":"print","value":"2666-6065"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100293"}}